Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Innovasis is a medical technology company specializing in the research, development, and commercialization of spinal implant, instrument, and biologic systems. Headquartered in Salt Lake City, Utah, the company provides a comprehensive portfolio of products designed to treat various spinal pathologies, including degenerative disc disease, deformity, and trauma. Key offerings include the Ax Pedicle Screw System, various interbody fusion devices made from PEEK and titanium, and the Bio-Graft line of biologics. In 2024, the company was acquired by Envista Holdings Corporation, serving as the foundation for Envista's strategic entry into the spine market. The company's products are widely utilized by orthopedic and neurosurgeons to improve clinical outcomes in spinal fusion procedures. Innovasis maintains a focus on innovation in materials, such as hydroxyapatite-coated PEEK and 3D-printed porous titanium.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Innovasis.